Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method. | Medicine (Baltimore) | 2023 | 37478222 | PubTator, text mining | PubMed |
| Extracellular vesicles in atherosclerosis and vascular calcification: the versatile non-coding RNAs from endothelial cells and vascular smooth muscle cells. | Front Med (Lausanne) | 2023 | 37469665 | PubTator, text mining | PubMed |
| Opposing gene regulatory programs governing myofiber development and maturation revealed at single nucleus resolution. | Nat Commun | 2023 | 37468485 | PubTator, text mining | PubMed |
| Integrated analysis of circRNA, lncRNA, miRNA and mRNA to reveal the ceRNA regulatory network of postnatal skeletal muscle development in Ningxiang pig. | Front Cell Dev Biol | 2023 | 37465009 | PubTator, text mining | PubMed |
| Staring at the onco-exaptation: the two-faced medley of an ancient retrovirus, HERVH. | J Clin Invest | 2023 | 37463444 | PubTator, text mining | PubMed |
| Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. | Nat Commun | 2023 | 37460463 | PubTator, text mining | PubMed |
| Synthetic lethality in large-scale integrated metabolic and regulatory network models of human cells. | NPJ Syst Biol Appl | 2023 | 37454223 | PubTator, text mining | PubMed |
| Interleukin-6 and pulmonary hypertension: from physiopathology to therapy. | Front Immunol | 2023 | 37449201 | PubTator, text mining | PubMed |
| A Cross-Talk about Radioresistance in Lung Cancer-How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies. | Int J Mol Sci | 2023 | 37446385 | PubTator, text mining | PubMed |
| Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches. | Int J Mol Sci | 2023 | 37445860 | PubTator, text mining | PubMed |
| Tissue-Specific Regulation of CFTR Gene Expression. | Int J Mol Sci | 2023 | 37445855 | PubTator, text mining | PubMed |
| Circular RNA as Therapeutic Targets in Atherosclerosis: Are We Running in Circles? | J Clin Med | 2023 | 37445481 | PubTator, text mining | PubMed |
| The Talented LncRNAs: Meshing into Transcriptional Regulatory Networks in Cancer. | Cancers (Basel) | 2023 | 37444543 | PubTator, text mining | PubMed |
| MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications. | Cells | 2023 | 37443725 | PubTator, text mining | PubMed |
| Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. | Cell Oncol (Dordr) | 2023 | 37434012 | PubTator, text mining | PubMed |
| Regulation of Long Noncoding RNA NEAT1/miR-320a/HIF-1α Competitive Endogenous RNA Regulatory Network in Diabetic Retinopathy. | Invest Ophthalmol Vis Sci | 2023 | 37432846 | PubTator, text mining | PubMed |
| Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. | Front Cell Dev Biol | 2023 | 37427373 | PubTator, text mining | PubMed |
| SARS-CoV-2 Covid-19 Infection During Pregnancy and Differential DNA Methylation in Human Cord Blood Cells From Term Neonates. | Epigenet Insights | 2023 | 37425024 | PubTator, text mining | PubMed |
| Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | 37416747 | PubTator, text mining | PubMed |
| Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy. | iScience | 2023 | 37416452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=24